SCHEMBL14727677

SCHEMBL14727677

C=C(C)C(=O)Oc1ccc(C2(c3ccc(OC(=O)C(=C)C)cc3C)CCCCC2)c(C)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.41
ATM Q13315 1/20 0.41
ELANE P08246 1/20 0.40
ESR1 P03372 4/20 0.34
ESR2 Q92731 2/20 0.34
HDAC4 P56524 1/20 0.34
THRB P10828 1/20 0.34
ACHE P22303 2/20 0.33
PPARA Q07869 1/20 0.33
ADORA3 P0DMS8 3/20 0.33
NR1H2 P55055 3/20 0.32
NR1H3 Q13133 3/20 0.32
PGR P06401 2/20 0.32
CHRM1 P11229 2/20 0.32
SLC6A2 P23975 2/20 0.32
SLC6A3 Q01959 2/20 0.32
CHRM2 P08172 1/20 0.32
AR P10275 1/20 0.32
NFKB1 P19838 1/20 0.32
NFKB2 Q00653 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14727692 0.86 KMT2A (0.32) KMT2AATMELANE
SCHEMBL14802305 0.84 PDE7A (0.40) KMT2ASMN1; SMN2
SCHEMBL14727716 0.83 HTT (0.43) KMT2ATHRBPPARARAB9AMEN1
SCHEMBL14700574 0.81 ACHE (0.41) KMT2AESR1ACHEADORA3PGR
SCHEMBL2703811 0.79 KMT2A (0.49) KMT2AATMELANEESR1ESR2
SCHEMBL23795424 0.76 ELANE (0.51) KMT2AATMELANEESR1ESR2
SCHEMBL30692737 0.76 ELANE (0.51) KMT2AATMELANEESR1ESR2
SCHEMBL15834709 0.75 ELANE (0.50) KMT2AATMELANEACHEPPARA
SCHEMBL7044116 0.75 ELANE (0.50) KMT2AATMELANEACHESMN1; SMN2
SCHEMBL14173047 0.74 PPARA (0.55) KMT2AATMELANEESR1ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8840807-B2 Polymerizable compound JNC CORPORATION (JP) 2014-09-23 US disclosed
US-8840807-B2 Polymerizable compound JNC CORPORATION (JP) 2014-09-23 US disclosed
US-20130048912-A1 POLYMERIZABLE COMPOUND JNC PETROCHEMICAL CORPORATION (JP) 2013-02-28 US disclosed
US-20130048912-A1 POLYMERIZABLE COMPOUND JNC PETROCHEMICAL CORPORATION (JP) 2013-02-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130048912-A1 POLYMERIZABLE COMPOUND PYM1, ZYX, CPNE4 KMT2A 617/4885ATM 2670/4885ELANE 2834/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.